Intestinal Research

IBD
Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study: Bhaskar Kante, Pabitra Sahu, Saurabh Kedia, Sudheer K. Vuyyuru, Kapil Soni, Maneesh Singhal, Raju Sharma, Govind Makharia, Vineet Ahuja; Intest Res. 2022;20(2):231-239. Published online February 8, 2022; DOI: https://doi.org/10.5217/ir.2021.00056
Web of Science 5 Crossref 4; Full text PubReader ePub PDF Supplementary Material

Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease: Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, Yew-Loong Leong, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong, Yen-Hsuan Ni, Shu-Chen Wei; Intest Res. 2022;20(2):224-230. Published online February 8, 2022; DOI: https://doi.org/10.5217/ir.2021.00042
Web of Science 6 Crossref 7; Full text PubReader ePub PDF Supplementary Material

0. Are thiopurines safe and effective for patients with NUDT15 heterozygosity?: Published online February 7, 2022

IBD
Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?: Jihye Park; Intest Res. 2022;20(1):1-2. Published online January 26, 2022; DOI: https://doi.org/10.5217/ir.2021.00170
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Landscape of inflammatory bowel disease in Singapore: Daren Low, Nidhi Swarup, Toshiyuki Okada, Emiko Mizoguchi; Intest Res. 2022;20(3):291-296. Published online January 7, 2022; DOI: https://doi.org/10.5217/ir.2021.00089
Web of Science 6 Crossref 7; Full text PubReader ePub PDF

Artificial intelligence for endoscopy in inflammatory bowel disease: Kento Takenaka, Ami Kawamoto, Ryuichi Okamoto, Mamoru Watanabe, Kazuo Ohtsuka; Intest Res. 2022;20(2):165-170. Published online January 7, 2022; DOI: https://doi.org/10.5217/ir.2021.00079
Web of Science 8 Crossref 5; Full text PubReader ePub PDF

Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements: Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung; Intest Res. 2022;20(4):431-444. Published online January 5, 2022; DOI: https://doi.org/10.5217/ir.2021.00111
Web of Science 1 Crossref 2; Full text PubReader ePub PDF

SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID: Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seung-Jae Myung, The Clinical Practice Guideline Committee of the Korean Association for the Study of the Intestinal Diseases (KASID); Intest Res. 2022;20(2):171-183. Published online January 5, 2022; DOI: https://doi.org/10.5217/ir.2021.00098
Web of Science 5 Crossref 5; Full text PubReader ePub PDF

Natural history of inflammatory bowel disease: a comparison between the East and the West: Eun Mi Song, Suk-Kyun Yang; Intest Res. 2022;20(4):418-430. Published online December 2, 2021; DOI: https://doi.org/10.5217/ir.2021.00104
Web of Science 22 Crossref 24; Full text PubReader ePub PDF

0. How often is immunoglobulin A nephropathy associated in patients with inflammatory bowel diseases?: Published online November 2, 2021

IBD
Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model: Jihye Park, Da Hye Kim, Soochan Kim, Hyun Woo Ma, I Seul Park, Mijeong Son, Ji Hyung Kim, Yoojin Shin, Seung Won Kim, Jae Hee Cheon; Intest Res. 2021;19(4):478-481. Published online October 26, 2021; DOI: https://doi.org/10.5217/ir.2021.00121
Web of Science 3 Crossref 3; Full text PubReader ePub PDF

Does cytomegalovirus load predict the outcome of acute severe ulcerative colitis?: You Sun Kim; Intest Res. 2021;19(4):357-359. Published online October 26, 2021; DOI: https://doi.org/10.5217/ir.2021.00120
Web of Science 3 Crossref 3; Full text PubReader ePub PDF

Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance: Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama, Yasuo Suzuki; Intest Res. 2022;20(3):329-341. Published online August 4, 2021; DOI: https://doi.org/10.5217/ir.2021.00032
Web of Science 3 Crossref 4; Full text PubReader ePub PDF Supplementary Material

Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease: Anthony Buisson, Lisa Cannon, Konstantin Umanskiy, Roger D. Hurst, Neil H. Hyman, Atsushi Sakuraba, Joel Pekow, Sushila Dalal, Russell D. Cohen, Bruno Pereira, David T. Rubin; Intest Res. 2022;20(3):303-312. Published online August 4, 2021; DOI: https://doi.org/10.5217/ir.2021.00018
Web of Science 4 Crossref 7; Full text PubReader ePub PDF Supplementary Material

Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation: Brigida Barberio, Edoardo Vincenzo Savarino, Timothy Card, Cristina Canova, Francesco Baldisser, Alessandro Gubbiotti, Davide Massimi, Matteo Ghisa, Fabiana Zingone; Intest Res. 2022;20(1):114-123. Published online August 4, 2021; DOI: https://doi.org/10.5217/ir.2021.00037
Web of Science 10 Crossref 10; Full text PubReader ePub PDF Supplementary Material

Search